Caribou Biosciences is Armoring Cells to Fight Disease Through CRISPR

Now, Haurwitz is the CEO and President of Caribou Biosciences, a precision cell engineering company using specially designed CRISPR technology to develop medical therapies. The company’s overarching aim is to edit and equip cells with molecular tools, through CRISPR, to eliminate certain cancers.